A Open-Label, Single Sequence Study to Assess the Pharmacokinetics and Pharmacodynamics of Simvastatin Alone and of Simvastatin in Combination With JNJ-28431754 in Healthy Adult Subjects
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Canagliflozin (Primary) ; Simvastatin
- Indications Diabetic cardiomyopathy; Dyslipidaemias; Obesity; Type 2 diabetes mellitus
- Focus Pharmacodynamics; Pharmacokinetics
- 03 Apr 2013 New trial record